J Lüdemann

876 total citations · 1 hit paper
12 papers, 673 citations indexed

About

J Lüdemann is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Surgery. According to data from OpenAlex, J Lüdemann has authored 12 papers receiving a total of 673 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Endocrinology, Diabetes and Metabolism, 6 papers in Molecular Biology and 2 papers in Surgery. Recurrent topics in J Lüdemann's work include Diabetes Treatment and Management (9 papers), Diabetes Management and Research (8 papers) and Metabolism, Diabetes, and Cancer (6 papers). J Lüdemann is often cited by papers focused on Diabetes Treatment and Management (9 papers), Diabetes Management and Research (8 papers) and Metabolism, Diabetes, and Cancer (6 papers). J Lüdemann collaborates with scholars based in United States, Germany and Denmark. J Lüdemann's co-authors include Vanita R. Aroda, Ildiko Lingvay, Adie Viljoen, Richard E. Pratley, Andrea Navarria, Markus Dworak, John Chan, Juliana H. Oliveira, Kun‐Ho Yoon and Miao Yu and has published in prestigious journals such as The Lancet Diabetes & Endocrinology, BMJ Open and Diabetic Medicine.

In The Last Decade

J Lüdemann

11 papers receiving 657 citations

Hit Papers

Semaglutide versus dulaglutide once weekly in patients wi... 2018 2026 2020 2023 2018 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Semaglutide versus dulaglutide once weekly in patients with type 2 diabetes (SUSTAIN 7): a randomised, open-label, phase 3b trial
    2018 559 citations Richard E. Pratley, Vanita R. Aroda et al. The Lancet Diabetes & Endocrinology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J Lüdemann United States 6 589 388 177 146 76 12 673
Srikanth Deenadayalan Denmark 5 485 0.8× 274 0.7× 154 0.9× 130 0.9× 88 1.2× 7 570
Marie‐Louise Hartoft‐Nielsen Denmark 11 439 0.7× 237 0.6× 96 0.5× 97 0.7× 60 0.8× 17 635
Astrid Breitschaft Denmark 11 406 0.7× 191 0.5× 165 0.9× 123 0.8× 90 1.2× 17 542
Masakazu Takeuchi Japan 13 479 0.8× 256 0.7× 130 0.7× 128 0.9× 72 0.9× 29 550
Charles Atisso United States 7 812 1.4× 465 1.2× 244 1.4× 253 1.7× 84 1.1× 18 864
Mario Widel United States 7 764 1.3× 430 1.1× 139 0.8× 281 1.9× 68 0.9× 11 922
Bryan Goldman Denmark 7 415 0.7× 203 0.5× 208 1.2× 116 0.8× 73 1.0× 11 514
P. Miossec France 12 991 1.7× 455 1.2× 204 1.2× 376 2.6× 83 1.1× 22 1.1k
Shizuka Kaneko Japan 11 847 1.4× 400 1.0× 287 1.6× 291 2.0× 188 2.5× 23 1.0k
Fred Yang United States 9 771 1.3× 386 1.0× 166 0.9× 300 2.1× 50 0.7× 17 867

Countries citing papers authored by J Lüdemann

Since Specialization
Citations

This map shows the geographic impact of J Lüdemann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J Lüdemann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J Lüdemann more than expected).

Fields of papers citing papers by J Lüdemann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J Lüdemann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J Lüdemann. The network helps show where J Lüdemann may publish in the future.

Co-authorship network of co-authors of J Lüdemann

This figure shows the co-authorship network connecting the top 25 collaborators of J Lüdemann. A scholar is included among the top collaborators of J Lüdemann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J Lüdemann. J Lüdemann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Pratley, Richard E., Vanita R. Aroda, Andrei‐Mircea Catarig, et al.. (2020). Impact of patient characteristics on efficacy and safety of once-weekly semaglutide versus dulaglutide: SUSTAIN 7 post hoc analyses. BMJ Open. 10(11). e037883–e037883. 13 indexed citations
2.
Aroda, Vanita R., Matthew Capehorn, Louis Chaykin, et al.. (2019). Impact of baseline characteristics and beta‐cell function on the efficacy and safety of subcutaneous once‐weekly semaglutide: A patient‐level, pooled analysis of the SUSTAIN 1‐5 trials. Diabetes Obesity and Metabolism. 22(3). 303–314. 20 indexed citations
3.
Goldenberg, Ronald, Richard E. Pratley, Vanita R. Aroda, et al.. (2019). 87 - Efficacy and Safety of Semaglutide 0.5 mg vs Dulaglutide 1.5 mg Once Weekly in Type 2 Diabetes: Posthoc Analysis of SUSTAIN 7. Canadian Journal of Diabetes. 43(7). S32–S32. 1 indexed citations
4.
Pratley, Richard E., Vanita R. Aroda, Ildiko Lingvay, et al.. (2018). Semaglutide versus dulaglutide once weekly in patients with type 2 diabetes (SUSTAIN 7): a randomised, open-label, phase 3b trial. The Lancet Diabetes & Endocrinology. 6(4). 275–286. 559 indexed citations breakdown →
5.
Jacob, Stephan, J Lüdemann, Kirstine Brown‐Frandsen, et al.. (2017). Liraglutid und renale Endpunkte bei Typ 2 Diabetes: Ergebnisse der LEADER Studie. Diabetologie und Stoffwechsel. 12(S 01). S1–S84. 3 indexed citations
6.
7.
Lüdemann, J, et al.. (2014). Tageszeitlich flexible Gabe von Insulin degludec bei Patienten mit Typ-1-Diabetes oder Typ-2-Diabetes. MMW - Fortschritte der Medizin. 156(S5). 89–97. 1 indexed citations
8.
Lüdemann, J, et al.. (2014). [Daytime flexible application of Insulin degludec in patients with type 1 diabetes or type 2 diabetes].. PubMed. 156 Suppl 3. 89–97. 1 indexed citations
9.
Lüdemann, J, et al.. (2013). Insulin degludec: Reduktion von Hypoglykämien unter einer Basis-Bolus Therapie bei Patienten mit Diabetes mellitus Typ 1 oder 2. Diabetologie und Stoffwechsel. 8(1). 35–42. 1 indexed citations
10.
11.
Schleier, Peter, Andrea Maria Schmidt‐Westhausen, Harry P. F. Peters, et al.. (2007). Ibuprofen sodium dihydrate, an ibuprofen formulation with improved absorption characteristics, provides faster and greater pain relief than ibuprofen acid. International Journal of Clinical Pharmacology and Therapeutics. 45(2). 89–97. 32 indexed citations
12.
Lüdemann, J, et al.. (2001). Leukocyte/Endothelium Activation and Interactions During Femoral Percutaneous Transluminal Angioplasty. Vascular Surgery. 35(4). 293–301. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Srikanth Deenadayalan Breakdown of academic impact, for papers by Marie‐Louise Hartoft‐Nielsen Breakdown of academic impact, for papers by Astrid Breitschaft Breakdown of academic impact, for papers by Masakazu Takeuchi Breakdown of academic impact, for papers by Charles Atisso Breakdown of academic impact, for papers by Mario Widel Breakdown of academic impact, for papers by Bryan Goldman Breakdown of academic impact, for papers by P. Miossec Breakdown of academic impact, for papers by Shizuka Kaneko Breakdown of academic impact, for papers by Fred Yang
Rankless by CCL
2026